BRETONZA
LIVE

Serial Number

79268427

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Aug 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

BRETONZA Trademark

Serial Number: 79268427 • Registration: 6015935

BRETONZA is a trademark filed by NOVARTIS AG on August 6, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

August 6, 2019

Registration Date

March 24, 2020

Published for Opposition

December 3, 2019

Cancellation Date

March 21, 2024

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Oct 16, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Oct 16, 2024 DETH
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2020 FINP
NOTIFICATION PROCESSED BY IB
Jun 12, 2020 GPNX
GENERIC MADRID TRANSACTION SENT TO IB
May 20, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
May 20, 2020 XXCR
FINAL DISPOSITION NOTICE SENT TO IB
May 5, 2020 FICS
FINAL DISPOSITION PROCESSED
May 5, 2020 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Apr 23, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Mar 24, 2020 R.PR
POST PUBLICATION AMENDMENT - ENTERED
Feb 20, 2020 CHPB
ASSIGNED TO PETITION STAFF
Feb 14, 2020 APET
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Feb 12, 2020 ETOP
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jan 6, 2020 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Dec 13, 2019 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2019 CNSA
ASSIGNED TO EXAMINER
Oct 25, 2019 DOCK
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2019 REAP
APPLICATION FILING RECEIPT MAILED
Oct 8, 2019 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 4, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 2, 2019 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Sep 26, 2019 SDRC